Jfri A. Dermatologic immune-related adverse events with immune checkpoint inhibitors. Can Dermatol Today [Internet]. 2022 Sep. 1 [cited 2024 Nov. 24];3(3):40–46. Available from: https://canadiandermatologytoday.com/article/view/3-3-jfri